Background
==========

Dissecting the specific effect of a drug on a defined biological process is often complicated by the plethora of secondary effects that arise during extended exposure. This is highlighted by the anti-cancer drug rapamycin whose principle, although not exclusive, target is the rate limiting initiation step of protein translation \[[@B1]\]. Techniques designed to analyse the effect of the drug on mRNA-ribosome association are hampered by the long exposure times required to observe changes in the polysomal mRNA populations. Translation initiation is frequently regulated via the *e*ukaryotic *i*nitiation *f*actor 4E (eIF4E). It can be sequestered into an inactive complex by a family of 4E-binding proteins (4E-BP1/2/3). The affinity of these proteins for eIF4E is modulated by phosphorylation via the mTORC1 (mammalian target of rapamycin complex 1) kinase \[[@B2]\]. Rapamycin arrests many cells in G~1~\[[@B3]\], and is a potent immunosuppressant \[[@B4]\]. It exerts its action by binding and inactivating the mTORC1 \[[@B5]\]. Previous studies have shown that extended exposure to rapamycin also alters transcription. Among the mRNAs regulated, a number impact directly on translation (e.g. eIF2α) \[[@B6]\]. These changes were minor after short drug exposure times (\< 60 mins), but increased markedly after 2 hrs. Translational profiling studies (which examine the mRNAs associated with ribosomes) have also been reported \[[@B7]-[@B10]\]. One study, performed on the Jurkat T cell clone E6-1, revealed that after an extended exposure to rapamycin (minimum 4 hrs) almost all transcripts analysed were inhibited, and 136 of those (representing \~5% of the total) were strongly inhibited (at least 10 fold). This latter group included a number of mRNAs whose products impact directly on translation (e.g. eIF5A, eIF4A1, eEF1, eEFTu) \[[@B8]\]. This would predict that lengthy exposure to the drug will influence translation by modifying the levels of initiation and elongation factors. We therefore sought to develop a technique that would permit a specific analysis on how the drug alters transcript recruitment onto free ribosomes under conditions that eliminated the secondary effects associated with extended exposure. The approach has been coupled to a high-throughput microarray screen to examine how rapamycin exposure impacts on the re-seeding of the polysomal transcript populations. Results from the array have also been validated by quantitative RT-PCR.

Methods
=======

Cell culture
------------

MRC-5 cells (Coriell Cell Repository) were cultured in Minimal Essential Medium (Gibco) supplemented with 1 mM sodium pyruvate (Sigma), 0.1 mM non-essential amino acids, 10% foetal calf serum (Brunschwig), 1% penicillin/streptomycin, in a humidified atmosphere containing 5% CO~2~. For polysome analysis, cells in the growing phase (60% confluence) were hypertonically shocked by shifting to medium containing 300 mM NaCl for 50 min. They were then placed in normal isotonic medium for 30 min. When rapamycin was used, 100 nM rapamycin (LC laboratories) or 0.01% DMSO (the negative control) was added during the hypertonic shock, 20 min before the transfer back to isotonic conditions. Rapamycin and DMSO were kept on the cells throughout the 30 mins recovery period (total time of exposure to rapamycin was 50 mins). These conditions were based upon previously published work \[[@B11]\], although we have independently confirmed that they can be used on a range of cell lines including 293T \[[@B12]\], HeLa S3 and SK-NA5 (data not shown).

Polysome gradient/RNA extraction
--------------------------------

After treatment, cells were scraped into the culture medium and pelleted for 4 min at 100 g. The pellets, consisting of 5 × 10^6^cells, were lysed for 15 min on ice in 400 μL of 100 mM KCl, 50 mM Tris-Cl pH 7.4, 1.5 mM MgCl~2~, 1 mM DTT, 1 mg/mL heparin, 1.5 % NP40, 100 μM cycloheximide, 1% aprotinin, 1 mM AEBSF and 100 U/mL of RNasin. Nuclei were pelleted by centrifugation in a microfuge, 10 min at 12000 rpm. The supernatant was loaded onto a 20--60% sucrose gradient (in 100 mM KCL, 5 mM MgCl~2~, 20 mM HEPES pH 7.4 and 2 mM DTT). Extracts were fractionated for 3 h 30 min at 35,000 rpm at 4°C in a Beckman SW41 rotor, and the gradients were recovered in 3 fractions \[monosome, light polysome (2 to 5 ribosomes) and heavy polysome (\> 5 ribosomes)\] using a Brandel gradient fractionator equipped with an ISCO UA-6 flow cell set to 254 nm. RNA was isolated from the light and heavy polysome fractions by adding an equal volume of TriZol (Invitrogen). Samples were mixed and incubate for 15 min. on ice, then 0.3 volumes of chloroform was added. After centrifugation, the upper phase was collected and the RNA precipitated with 0.7 volumes of isopropanol. The pellet of RNA was re-suspended in water. Prior to microarray analysis the pooled RNA fractions were further purified using the Qiagen RNeasy kit. The total yield of RNA in each pooled fraction was \~2 μg. RNA quality was checked on an Agilent 2100 bioanalyser.

Microarray
----------

Total RNA (100 ng from each fraction) was first amplified using the two step amplification protocol of Affymetrix. cRNA (17.5 μg) was then used to probe the Gene Chip U133 Plus 2.0 with 54,675 probe sets, covering more than 47,000 transcripts. Three biological replicates were hybridised for each condition (light and heavy polysomes +/- rapamycin). Data were analysed using the GCOS normalisation of Affymetrix. After normalisation, we filtered out probe sets that were assayed \"absent\" in all the 12 arrays. For this, the expression levels in each control experiment (DMSO) were arbitrarily fixed to one, and the fold change of the corresponding probe in the treated samples was normalised to this. The variation was then tested using the Mann and Witney U statistical test. Using this approach 24,105 of the probe sets (44%) were flagged as absent. The data was further analysed using two approaches. Firstly, probe set intensity values below 100 were removed prior to GCOS normalisation, and fold changes ≥ 1.5 relative to the DMSO control were scored (the smallest score in the three independent experiments had to show at least a 20% change relative to the DMSO control i.e. a 1.2 fold increase or a 0.8 fold decrease). In a second approach, commencing with the entire data set, points were only scored if the mean of the fold difference was ≥ 2.5 (once again the smallest score in the three independent experiments had to show at least a 20% change relative to the DMSO control). The data from both screens were plotted onto biological networks using the GO onthology (Affymetrix) and Ingenuity Pathway Analysis Software packages <http://www.Ingenuity.com>.

The microarray data are available at ArrayExpress (Accession N° E-TABM-205).

Real-Time PCR
-------------

One μg of total RNA from a fourth independent experiment was reverse transcribed using random hexamers (Gibco). A 1/10 dilution of the cDNA was used to perform the PCR with the SYBR Green Reagent (Roche).

Primers used were:

**QKI**AGCATCACAGTCAGAGGTCAGC, GCAGTGGCATATTAAACCAAAGC;

**RBM7**GTTGGAAATTCAAGCCCTACCT, AATCCTGATTGATCCAGAGGTG;

**ORMDL1**GTCTGGCAGAAACAACGTCTC, CAATGTGGTTGCTGTTCTGG;

**FAS**GATGGCGAATGAGGTTCAG, CAATCCCATATCTCCCATTAAC;

**RBM17**GTCATCTCCGGTGATCCTTAAA, CAACCAGAGAGGCACACAGAT;

**PAPPA**GCATCAGTTTCTCTAGCTGCAA, TATCAAACAAGCACTCCCTGTC;

**Actin**CTGACGGCCAGGTCATCACCATTG, GCCGGACTCGTCATACTCCTGCTTG;

**L27**GTGACAGCTGCCATGGGCAAG, TCAAACTTGACCTTGGCCTCCCG,

**Cyclin D1**AAGCAGGACTTTGAGGCA AG, CCTCTGAGGTCCCTACTTTCAA.

Primer sets were designed to amplify regions within the 3\' UTR of each transcript since this generally corresponded to the site of the probe sets used on the Affymetrix chip. The specificity of each primer set was confirmed by standard RT-PCR on total cell RNA, followed by analysis of the DNA products by agarose gel electrophoresis (data not shown).

Western blot analysis
---------------------

Cells were lysed in CSH buffer (50 mM Tris-Cl pH 7.5, 250 mM NaCl, 1 mM EDTA, 0.1% Triton X-100) and the nuclei were pelleted by centrifugation at 12,000 rpm for 5 mins. Twenty μgs of protein was resolved on a 15% polyacrylamide-SDS gel and electrotransfered to a PVDF membrane. Antibodies used in this study were the anti-4EBP1 (Cell Signalling), the anti-phosho4EBPI (Thr37/46) (Cell Signalling), the anti-p70 S6 kinase (Cell Signalling), the anti-phospho-p70 S6 kinase (Thr389) (Cell Signalling) and mouse anti-actin (Chemicon). Blots were developed using the Super Signal Substrate (Thermo Scientific).

Results
=======

Rapamycin delays mRNA recruitment onto polysomes
------------------------------------------------

To directly examine the effect of rapamycin on mRNA recruitment we decided to exploit a novel approach, an approach that analyses the ability of cellular mRNAs to compete for free ribosomes in-vivo. Hypertonic shock provokes a rapid inhibition of protein synthesis, disaggregation of polysomes (Figure [1A](#F1){ref-type="fig"}), dephosphorylation of eIF4E, 4E-BP1, S6 and an increased association of eIF4E and 4E-BP1 \[[@B11],[@B13]\]. Upon restoration of isotonic conditions the polysomal fraction is rapidly reconstituted (Figure [1B](#F1){ref-type="fig"} and \[[@B11]\]). Using this methodology it was possible to examine what effect rapamycin had on the recruitment of mRNA populations onto free ribosomes following very short drug exposure times. It was in substance an in-vivo competition assay performed under two defined physiological conditions. Drug treatment appeared to delay recruitment as evidenced by the reduction in the heavy polysome peak (≥ 6 ribosomes: compare Figure [1B](#F1){ref-type="fig"} and [1C](#F1){ref-type="fig"}), and this effect was correlated with a modification of the downstream signalling targets of mTOR, including 4E-BP1 and S6 kinase. (Figure [1D](#F1){ref-type="fig"}, compare the second and third lanes). This confirmed that despite the relatively short time of exposure to rapamycin, the recruitment assay monitored transcript:ribosome re-association under two conditions in which eIF4E availability was altered.

![**Ribosomal re-recruitment in the presence of rapamycin**. (A). High salt provokes a rapid disaggregation of polysomes. (B). Upon restoration of isotonic conditions the polysomal fraction is reconstituted (C). Pre-treatment with rapamycin delays the re-recruitment of ribosomes. The position of the ribonucleoprotein (RNP), the monosomal (Mono) and polysomal (Poly) fractions are indicated. (D) Western blot analysis of phospho-4EBP-1, 4EBP-1, phospho-S6K, S6K, and actin was performed on extracts isolated under the different conditions depicted in panels (A); (B) and (C).](1755-8794-1-33-1){#F1}

A profiling screen identifies changes in the light and heavy polysomal mRNA populations
---------------------------------------------------------------------------------------

Equal amounts of RNA isolated from the light (2 to 5 ribosomes) and heavy (\> 5 ribosomes) polysomal fractions were used to probe the Affymetrix Gene Chip U133 Plus 2. Triplicate independent gradients under each experimental condition were examined. After data analysis, two subpopulations of transcripts were clearly discriminated: those dominant in the light polysomal fraction and those dominant in the heavy polysomal fraction, an important criterion since it validated the initial experimental approach (Figure [2A](#F2){ref-type="fig"}). Despite the fact that the polysomal peaks were smaller in the presence of rapamycin, consistent with a global repression, the two sub-populations were essentially conserved (i.e. no major movement of mRNA populations between the two fractions as a consequence of the treatment was evident). To analyse the data we used two approaches. Firstly, we filtered out all transcripts giving low probe set intensity values on the chip using the default settings of the Agilent analysis software package (values \< 100). We then scored for mRNAs whose polysomal occupancy was altered by greater than ×1.5 fold (listed in Additional File [1](#S1){ref-type="supplementary-material"}). This produced 437 transcripts within which was found the majority of the repressed TOP mRNAs (see below). Curiously, within this group of transcripts almost equal proportions were up and down-regulated (46% and 54%, respectively) (Figure [2B](#F2){ref-type="fig"}).

![**Microarray analysis**. (A). Hierarchical clustering of relative expression. Each column represents the different conditions. On the right the vertical bar indicates probe set intensity values (indicated as Expression) in arbitrary units. The zero value indicates absence, with blue indicating a low level and red a high level of expression (the maximum value being fixed as 5). The vertical brackets on the right indicate that transcripts have been grouped into those over-represented in the light polysomes (lower) or in the heavy polysomes (upper). (B). After removal of probe set intensity values \< 100, and the application of a ×1.5 fold cut-off, the regulated genes were classified into four groups. The values indicate the number of transcripts in each group. (C). In a second approach, a ×2.5 fold cut-off was applied. (D) and (E). Functional classification using Gene Ontology of the genes either up-regulated or down-regulated (as depicted in panel b and in Additional File [1](#S1){ref-type="supplementary-material"}, and panel c and in Additional File [2](#S2){ref-type="supplementary-material"}, respectively). The unknown fraction represents genes not annotated in the Gene Ontology database.](1755-8794-1-33-2){#F2}

As a second approach to analyse the data we applied a ×2.5 fold change cut-off point to the entire data set. The rationale for this alternative analysis is based upon the fact that many of the genes that are regulated at the level of translation are frequently transcribed at low levels. This includes proto-oncogenes and other factors that regulate cell growth \[[@B14]\]. The majority of these transcripts are found within the lower intensity range and we therefore tested if meaningful information could be extracted from this region by applying a more stringent selection. We observed that 1160 mRNAs (3.8%) showed increased or decreased polysomal distribution in the presence of rapamycin, suggesting that in this small fraction of transcripts the affinity for the cap binding complex was changed (Figure [2C](#F2){ref-type="fig"} and Additional File [2](#S2){ref-type="supplementary-material"}). Over 2/3 of the mRNAs responding to the drug were down-regulated, whereas 1/3 showed increased polysomal occupancy relevant to the non-treated control. Only a few transcripts were regulated in both the heavy and the light polysomes (55 mRNAs) (Figure [2C](#F2){ref-type="fig"}). These results are not unlike those reported in a translational profiling study performed on the two tumoural cell lines, LAPC-4 (prostrate cancer) and U87 (glioblastoma). Applying the 2.5 fold cut-off point, ca. 6% of the 3,000 transcripts screened showed altered polysomal occupancy, and amongst these, 60% were down-regulated and 40% up-regulated \[[@B7]\].

Those mRNAs showing significant redistributions (both increased and decreased: as listed in Additional Files [1](#S1){ref-type="supplementary-material"} and [2](#S2){ref-type="supplementary-material"}) were then plotted onto cellular networks using the GO onthology (Affymetrix) software package. Results revealed that transcripts up- or down-regulated affected more or less the same biological processes (Figure [2D](#F2){ref-type="fig"} and [2E](#F2){ref-type="fig"}). However, using the Ingenuity pathway analysis a number of features were immediately evident in the rapamycin treated cells: (a) A group of mRNAs involved in the inflammatory response were regulated, consistent with the immunosuppressive activity of rapamycin. Interestingly, we also observed down-regulation of several transcripts linked to phagocytosis. It has recently been reported that rapamycin down-regulates phagocytosis in a murine macrophage cell line (Table [1](#T1){ref-type="table"}) \[[@B15]\]. (b) We observed a number of mRNAs involved in cell growth and proliferation. Among them, a number of anti-apoptotic mRNAs were up-regulated (e.g. relA and mdm2), whereas pro-apoptotic ones were down-regulated (e.g. fas, faslg and faf1) (Table [1](#T1){ref-type="table"}). This is consistent with the observation that rapamycin did not induce apoptosis in MRC-5 cells even after extended exposure (unpublished observations), and corroborated recent studies showing the anti-apoptotic properties of rapamycin \[[@B16],[@B17]\].

###### 

List of transcripts regulated by rapamycin (Ingenuity classification)

  **Inflammation**                                                                                
  ----------------------------------- ------------------- --------- ---------- -------- --------- ----------
  **Upregulated**                     **Downregulated**                                           
                                                                                                  
  apobec3f                            lst1                adra1a    epha4      il1rn    ptpn22    tlr7
  blnk                                mdm2                adra2c    f9         irf2     ptprc     zeb1
  cald1                               oas1                alpp      fas        itgb3    ptprz1    
  cmklr1                              parvg               bcl11a    faslg      klf2     rbl2      
  ctla4                               pdgfc               bcl2l1    fcgr2a     lama3    rbm15     
  cxcr4                               rag2                cast      folr1      lilra2   rbpj      
  cyp3a4                              rela                cd28      fyb        mll      rel       
  fyn                                 sat1                cd36      gal        mpo      satb1     
  hla-g                               tcf12               clec1b    gap43      pcgf2    siglec8   
  ifih1                               tfap4               cul4a     gnrh1      pla2g6   smpd1     
  ifna2                               thbs1               cxcl11    gnrhr      plcg1    spn       
  il16                                tlr7                cyp3a4    hal-dqb1   prdm16   syk       
  il28b                               unc119              ddl1      hck        pscdbp   thra      
  itga4                               vtcn1               dok2      ifne1      ptgs2    thrb      
                                                                                                  
  **Cell growth and proliferation**                                                               
                                                                                                  
  **Upregulated**                     **Downregulated**                                           
                                                                                                  
  adam12                              mdm2                adra1a    dok2       gnrh1    olig2     rffl
  blnk                                pappa               bcl2l1    f12        hck      p53aip1   sec14l2
  cdc2l5                              rag2                ccl27     fas        hmga2    pcgf2     syk
  ctla4                               rela                cd28      faslg      irf2     pdgfa     tfr2
  cxcr4                               s100b               cdca7     fbxo2      itgb3    piwil1    tgif1
  erbb3                               ss18                clca2     fcer2      klf2     pla2g6    thra
  fyn                                 tcf12               cltc      fgf18      lzts1    ptgs2     thrb
  hla-g                               thbs1               csh2      folr1      mdm4     ptk2      tnfsf15
  igf1r                               unc119              cyp2c9    foxo1      mll      ptpn22    zfn10
  il28b                               vtcn1               dcc       gal        nab2     ptpra     
  itga4                                                   ddx17     gap43      nos1     ptprc     
  lst1                                                    dll1      glmn       nov      rbl2      
                                                                                                  
  **Cell death**                                                                                  
                                                                                                  
  **Upregulated**                     **Downregulated**                                           
                                                                                                  
  blnk                                itga2               abcd2     dll1       hmga2    p53aip1   rbm17
  cdk6                                mdm2                acvr1b    eraf       ifne1    pigt      rel
  ctla4                               rag2                adora2a   faf1       il1rn    piwil1    satb1
  cul3                                rela                atrx      fas        irf2     pla2g6    serpinb4
  cxcr4                               rnase1              atxn3     faslg      itgb3    pou4f1    siglec8
  cyp2e1                              sgpp1               bcl2l1    fcer2      klf2     ppp1r9b   smpd1
  cyp3a4                              tfap4               bircabp   foxo1      klra1    ppp2r1b   spn
  erbb3                               thbs1               cast      gal        lrp5     prdm2     stk4
  erg                                 traf4               ccl27     gimap5     mdm4     ptgs2     syk
  fyn                                 zmym2               cd28      gng2       mll      ptk2      thra
  hla-g                                                   cdk6      gria2      mpo      ptpn22    tnfsf15
  ifih1                                                   cyp2e1    grik2      nol3     ptprc     traf5
  ifna2                                                   cyp3a4    grm1       nos1     ptprz1    trps1
  igf1r                                                   dcc       hint1      nrtn     rbl2      znf10
                                                                                                  
  **Phagocytosis**                                                                                
                                                                                                  
  **Upregulated**                     **Downregulated**                                           
                                                                                                  
                                                          cd36      klf2                          
                                                          fas       mpo                           
                                                          fcgr2a    pla2g6                        
                                                          hck       syk                           
                                                          itgb3                                   

The 1160 mRNAs identified in the microarray screen (as listed in Additional File [2](#S2){ref-type="supplementary-material"}) were plotted onto biological networks using the Ingenuity Pathway Analysis Software package. Those whose protein products are involved in inflammation, phagocytosis, cell growth/proliferation and cell death are listed.

Rapamycin is known to have a marked effect on the expression of a subset of transcripts referred to as terminal oligopyrimidine (TOP) mRNAs \[[@B18]\]. This includes ribosomal protein mRNAs (estimated to be \~15% of the total cellular mRNA) and translation elongation factors. In previous translational profiling studies, a number of TOP mRNAs were clearly repressed. We also observed repression of ribosomal transcripts, although the effects were less extensive than in the earlier reports. This may reflect both the shorter drug exposure times and the experimental approach that was employed (i.e. mRNA re-recruitment onto free ribosomes). With the cut-off threshold at ×2.5 fold we observed down regulation of rpl14 and rpl21 in the light polysomes and rplp0 in the heavy polysomes (*r*ibosomal *p*rotein *l*arge). However, if the threshold was reduced to ×1.5 fold the number of hits significantly increased. Most significantly, ribosomal transcripts were only ever observed down-regulated (Table [2](#T2){ref-type="table"} and Additional File [1](#S1){ref-type="supplementary-material"}).

###### 

List of TOP mRNAs detected in the array.

  **LIGHT POLYSOME UP**   **LIGHT POLYSOME DOWN**           **HEAVY POLYSOME DOWN**
  ----------------------- --------------------------------- ---------------------------------
  (NONE)                  rpl5 (-1.5)                       rplP0 (-2.7)
                          rpl14 (-2.5)                      rpl36 (-1.5)
                          rpl21 (-5.1)                      eef2 (-1.5)
                                                            
  **HEAVY POLYSOME UP**   rpl38 (-1.5)                      (translation elongation factor)
                                                            
  (NONE)                  rps11 (-2.1)                      
                          rps19 (-1.5)                      
                          rps21 (-2.1)                      
                          rps28 (-1.6)                      
                          eftuD1 (-5.5)                     
                          (translation elongation factor)   

Independent confirmation of the array results by RT-PCR
-------------------------------------------------------

With the aim of validating the microarray we performed real-time RT-PCR on selected transcripts across the spectrum of probe set intensities (Figure [3A](#F3){ref-type="fig"}). We were particularly interested in those transcripts that gave low probe set values. For the RT-PCR, RNA was extracted from a fourth independent experiment. Nine mRNAs were initially selected (Transcripts up-regulated = qki, rbm7, ormdl1. Transcripts down-regulated = fas, rbm17, pappa, Transcripts not regulated = β-actin, L27, cyclin D1: see Additional Files [1](#S1){ref-type="supplementary-material"} and [2](#S2){ref-type="supplementary-material"}). Transcripts from the lower values of the data set (see Additional File [2](#S2){ref-type="supplementary-material"} and Figure [3A](#F3){ref-type="fig"}) were selected because of the large fold difference between the rapamycin and DMSO control (\> 2.5 fold). The results, with the exception of those obtained with the pappa transcript, largely confirmed the micro-array data (Figure [3B](#F3){ref-type="fig"}). This was particularly encouraging for transcripts such as those coding for QKI and FAS, indicating that application of the ×2.5 fold cut-off approach permitted the extraction of useful hits even in the lower end of the probe intensity set (Figure [3A](#F3){ref-type="fig"}). Note that the absence of a light RT-PCR value for RBM17 simply reflected its low levels in this fraction (Ct \> 35 cycles). The microarray study also indicated that this transcript was regulated only within the heavy polysomal fraction, a result confirmed by the RT-PCR. In addition, these studies also demonstrated that no significant changes in total mRNA levels had occurred within the selected transcripts as a consequence of drug exposure (Figure [3B](#F3){ref-type="fig"}).

![**Real-Time RT-PCR analysis**. (A). A schematic representation of the intensity values of transcripts selected for the RT-PCR validation. In the upper panel, the horizontal bars represented the value range for each mRNA on the array. The lower panel plots the distribution of regulated genes (×2.5 fold cut-off selection) relative to the probe set values. (B). RT-PCR values were normalised to those obtained from two housekeeping genes and the fold change indicates the difference in the DMSO and rapamycin values after normalisation. The DMSO value was arbitrarily set at 1. The results are compared with those obtained from the microarray. The variation in the total mRNA extracted is also represented. The 2.5 fold difference used for the screening is represented by the dotted lines (2.5 and 0.4). Each bar is representative of 2 independent RT-PCR assays performed in triplicate. Bars indicate the SEM.](1755-8794-1-33-3){#F3}

Discussion
==========

In this technical report, we have outlined a novel approach to translational profiling that follows the impact of a drug on the de-novo re-association of mRNAs and ribosomes in living cells in culture. An intracellular pool of free ribosomes was generated by a short hypertonic shock. Although this undoubtedly induced a stress response, previous work has demonstrated that the translation initiation machinery recovers very rapidly after the cells are transferred back to isotonic conditions as monitored by the reconstitution of the polysomal fraction \[[@B11],[@B13]\]. The rapidity at which the polysomes are reformed has permitted us to examine the effect of a drug on this process using a short time window of exposure. This has the effect of limiting undesirable secondary effects that arise upon extended exposure, an effect highlighted by the drug selected for this study, namely rapamycin (see Introduction). The short exposure time warranted a drug concentration higher than that generally used in animal studies \[[@B19]\], however, some studies in cell culture systems have employed rapamycin concentrations as high as 15--20 μM before observing an impact on cell growth \[[@B20]\]. The selection was also dictated too by the fact that rapamycins\' effect on translation initiation has been extensively studied. We have demonstrated that this approach can be coupled to a high-throughput analysis of the polysomal transcript populations.

Treatment with rapamycin limits the availability of eIF4E via its sequestration into an inactive complex with the hypophosphorylated 4E-BPs. Such a scenario represses global translation rates but with an effect more marked on those mRNAs containing structured 5\' UTRs and those containing TOP elements. Indeed, when TOP containing transcripts were identified in our array they were always down-regulated (Table [2](#T2){ref-type="table"}). Additionally, although the polysome profiles demonstrated an overall translational repression, the position of the vast majority of mRNAs on the gradient (i.e. the transcript populations in both the heavy and light polysomes) was largely unperturbed by the drug (i.e. there was little movement of transcripts from heavy to light polysomes, a somewhat unanticipated response), indicating that the affinity of re-recruitment of ribosomes onto these mRNAs (as reflected by the number of ribosomes per transcript) was largely unchanged.

A number of translational profiling studies examining the effect of rapamycin in mammalian cells have already been reported. In one of these, the effect of rapamycin on the polysomal distribution of mRNAs was demonstrated to be coupled to the activity of AKT \[[@B7]\], a result that demonstrates the extent to which a drugs effect can be modulated by the physiological status of the cell. This interpretation has become even more convoluted following the observation that prolonged rapamycin treatment may inhibit AKT signalling by interfering with the assembly of the second mTOR complex, mTORC2 \[[@B21]\]. However, with regards to the two transcripts characterised in this work as strongly up-regulated, namely cyclin D1 and c-myc, the former was down-regulated in our screen (×1.5 fold), and the latter gave values that were not considered statistically significant. Other studies have also failed to observe changes in the polysomal occupancy of the cyclin D1 mRNA in the presence of rapamycin \[[@B9],[@B10],[@B22]\]. These differences may reflect the cell lines and/or the experimental procedures employed. Both cyclin D1 and c-myc were proposed to carry IRESes within the 5\' UTR, and IRES activity has been reported to show cell type specificity linked to the availability of ITAFs (*I*RES *T*rans-*A*cting *F*actors) \[[@B23]\]. Furthermore, the responsiveness of these IRESes to rapamycin was shown to be tightly coupled to the cellular activity of the AKT and RAF/MEK/ERK signalling cascades, features that may also show cell-type variation \[[@B24]\]. However, the slight reduction that we observed in the polysomal levels of the cyclin D1 mRNA would be consistent with other reports indicating that its expression was sensitive to the levels of eIF4E \[[@B25],[@B26]\]. Finally, the earlier profiling study followed changes in the steady-state polysomal populations after extended exposure to the drug, whilst in the current work we have followed a competitive re-association. These processes may have altered initiation factor requirements, which could impact on the mRNA populations that respond. Indeed, it has been proposed that eIF4GII but not eIF4GI is required for re-initiation subsequent to a hypertonic shock \[[@B27]\]. Nonetheless, a listing of transcripts detected in both studies demonstrated that the majority behaved similarly (see Additional File [3](#S3){ref-type="supplementary-material"}).

Conclusion
==========

In summary, a major effort is underway to use high density microarray profiles to study how different drug regimes impact on the polysomal mRNA populations. These studies provide insights into how cellular gene expression is regulated at the level of translation initiation, the rate limiting step in protein expression. Changes in this read-out are a very rapid cellular response to physiological perturbations. The method that we have outlined permits a specific analysis of how a drug impacts on transcript-ribosome association. This early response almost certainly conditions subsequent cell behaviour during extended exposure. The choice of rapamycin for this \"proof-of-principle\" work was not arbitrary since the impact of this drug on translation initiation has been extensively studied. The technique offers the possibility of establishing molecular fingerprints for different tumour derived cell types and drug regimes \[[@B28]\]. In addition, it provides a very powerful technique to analyse the early events in translational control at the level of mRNA:ribosome association.
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